Pirodomast
CAS No. 108310-20-9
Pirodomast( —— )
Catalog No. M36113 CAS No. 108310-20-9
Pirodomast is a thromboxane A (TXA2) synthase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 246 | Get Quote |
|
| 5MG | 371 | Get Quote |
|
| 10MG | 561 | Get Quote |
|
| 25MG | 868 | Get Quote |
|
| 50MG | 1178 | Get Quote |
|
| 100MG | 1557 | Get Quote |
|
| 500MG | 3114 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePirodomast
-
NoteResearch use only, not for human use.
-
Brief DescriptionPirodomast is a thromboxane A (TXA2) synthase inhibitor.
-
DescriptionPirodomast is a thromboxane A (TXA2) synthase inhibitor. Pirodomast inhibits leukotriene (LT) D4, C4, E4 formation and thromboxane B2 (TXB2) activity, but is weakly or ineffectively antagonistic to guinea pig bronchospasm induced by histamine, methacholine, serotonin, LTC4, or platelet-activating factor. Pirodomast is a potential antiallergic compound. Pirodomast had only weak relaxant activity on guinea pig trachea in vitro. Pirodomast is a potential antiallergic compound that inhibits the protein hydrolyzing activity of trypsin in vitro, prevents antigen-induced immediate and late asthmatic responses in allergic sheep in vivo, and inhibits antigen-induced airway hyperresponsiveness to histamine and carbachol in allergic sheep.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetThrombin
-
RecptorThrombin | Serine Protease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number108310-20-9
-
Formula Weight307.35
-
Molecular FormulaC18H17N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N(C=2C(C(=O)C1N3CCCC3)=CC=CN2)C4=CC=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Enoxaparin sodium
Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention (PCI).
-
Dabigatran etexilate
A prodrug of BIBR-953, which is a potent nonpeptide thrombin inhibitor with Ki of 4.5 nM.
-
Dabigatran etexilate...
A prodrug of BIBR-953, which is a potent nonpeptide thrombin inhibitor with Ki of 4.5 nM.
Cart
sales@molnova.com